Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence

Substance Use and Misuse

Volumn 41, Issue 6-7, 2006, Pages 777-813

  Wodak, Alex ^a,b   Cooney, Annie ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b Australian Drug Law Reform Foundation   (Australia)

Author keywords

Bradford Hill criteria; Bridge populations; Cost effective; Cost saving; Criminal justice approach; Harm reduction; HIV; Public health approach; Risk factor; Safe; Zero tolerance

Indexed keywords

BRADFORD HILL CRITERIA; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; EVALUATION; EVIDENCE BASED PRACTICE; HARM REDUCTION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INJECTION DRUG USER; INTRAVENOUS DRUG ABUSE; NEEDLE; NEEDLE AND SYRINGE PROGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SYRINGE; UNITED STATES;

COST-BENEFIT ANALYSIS; HARM REDUCTION; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; NEEDLE-EXCHANGE PROGRAMS; PUBLIC HEALTH; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33745728263     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080600669579     Document Type: Review

References (131)

1. Abdala, N., Stephens, P. C., Griffith, B. P., Heimer, R. (1999). Survival of HIV-1 in syringes. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 20:73-80.
2. Bastos, F. I., Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programes: current issues and future prospects. Social Science & Medicine 51:1771-1782.
3. Bluthenthal, R. N., Gogineni, A., Longshore, D., Stein, M. (2001). Factors associated with readiness to change drug use among needle-exchange users. Drug & Alcohol Dependence 62:225-230.
4. Bluthenthal, R. N., Kral, A. H., Erringer, E. A., Edlin, B. R. (1998). Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18:505-511.
5. Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 14:605-611.
6. Bradford Hill, A. (1965). The environment and disease: association or causation. Procedures of the Royal Society of Medicine 58:295-300.
7. Broadhead, R. S., van Hulst, Y., Heckathorn, D. D. (1999). The impact of a needle exchange's closure. Public Health Reports 114:439-447.
8. Bruneau, J., Lamothe, F., Franco, F., Lachance, N., Désy, M., Soto, J., Vinclette, J. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. American Journal of Epidemiology 146:994-1002.
9. Buchanan, D., Shaw, S., Ford, A., Singer, M. (2003). Empirical science meets moral panic: an analysis of the politics of needle exchange. Journal of Public Health Policy 24:427-444.
10. Burns, S. M., Brettle, R. P., Gore, S. M., Peutherer, J. F., Robertson, J. R. (1996). The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. Journal of Infection 32:53-62.
11. Chitwood, D. D., McCoy, C. B., Inciardi, J. A., McBride, D. C., Comerford, M., Trapido, E., McCoy, H. V., Page, J. B., Griffin, J., Fletcher, M. A., Ashman, M. A. (1990). HIV seropositivity of needles from shooting galleries in South Florida. American Journal of Public Health 80:150-152.
12. Chitwood, D. D., Griffin, D. K., Comerford, M., Page, J. B., Trapido, E. J., Lai, S., McCoy, C. B. (1995). Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. American Journal of Public Health 85:1538-1542.
13. Coutinho, R. A. (1998). HIV and hepatitis C among injecting drug users: success in preventing HIV has not been mirrored for hepatitis C. British Medical Journal 317:424-425.
14. Coutinho, R. A. (2000). Needle exchange, pragmatism, and moralism [letter;comment]. American Journal of Public Health 90:1385-1387.
15. Cox, G. M., Lawless, M. C., Cassin, S. P., Geoghegan, T. W. (2000). Syringe exchanges: a public health response to problem drug use. Irish Medical Journal 93:143-146.
16. Crofts, N., Aitken, C. K., Kaldor, M. J. (1999). The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia 170:220-221.
17. Des Jarlais, D. C., Friedman, S. R., Sotheran, J. L., Wenston, J., Marmor, M., Yancovitz, S. R., Frank, B., Beatrice, S., Mildvan, D. (1994). Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA 271:121-127.
18. Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., Green, S., Tunving, K., Ljungberg, B., Wodak, A. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 274:1226-1231.
19. Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., Jose, B., Friedman, S. R. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. The Lancet 348:987-991.
20. Des Jarlais, D. C., Perlis, T., Friedman, S., Chapman, T., Kwok, J., Rockwell, R., Paone, D., Milliken, J., Monterroso, E. (2000). Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. American Journal of Public Health 90:1112-1116.
21. Doherty, M. C., Junge, B., Rathouz, P., Garfein, R. S., Riley, E., Vlahov, D. (2002). The effect of needle exchange program on numbers of discarded needles: a 2-year follow-up. American Journal of Public Health 90:936-939.
22. Dolan, K., Rutter, S., Wodak, A. D. (2003). Prison-based syringe exchange programmes: a review of international research and development. Addiction 98:153-158.
23. Dolan, K., Wodak, A., Hall, W., Kaplan, E. (1998). A mathematical model of HIV transmission in NSW prisons. Drug & Alcohol Dependence 50:197-202.
24. Donoghoe, M. C., Dolan, K., Stimdon, G. V. (1992). Life-style factors and social circumstances of syringe sharing in injecting drug users. British Journal of Addiction 87:993-1003.
25. Donoghoe, M. C., Stimson, G. V., Dolan, K., Alldritt, L. (1989). Changes in HIV risk behaviour in clients of syringe-exchanges schemes in England and Scotland. AIDS 15:267-272.
26. Fennema, J. S. A., van Ameijden, E. J. C., van den Hoek, A., Coutinho, R. A. (1997). Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 92:1457-1466.
27. Frischer, M., Elliot, L. (1993). Discriminating needle exchange attender from non-attenders. Addiction 88:681-687.
28. General Accounting Office. (1993). Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. Washington, DC: U.S. Government Printing Office.
29. Gibson, D. R. (2000). Two- to sevenfold decreased risk associated with use of needle exchange. Paper presented at University of California 3rd annual Conference on AIDS Research in California, 17th Annual AIDS investigators' Meeting, University of California, South San Francisco, California.
30. Gibson, D. R., Brand, R., Anderson, K., Kahn, J. G., Perales, D., Guydish, J. (2002). Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiency Syndromes 31:237-242.
31. Gibson, D. R., Flynn, N. M. (2001). Some Observations Concerning the Contrary Evidence of Syringe Exchange Effectiveness. University of California, San Francisco: AIDS Research Institute.
32. Gibson, D. R., Flynn, N. M. (2001). Some Observations Concerning the Contrary Evidence of Syringe Exchange Effectiveness. Barcelona: AIDS Research Institute, University of California, San Francisco.
33. Gibson, D. R., Flynn, N. M., Perales, D. (2001). Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15:1329-1341.
34. Gleghorn, A. A., Jones, T. S., Doherty, M. C., Celentano, D. D., Vlahov, D. (1995). Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 10:97-103.
35. Gleghorn, A. A., Wright-De Aguero, L., Flynn, C. (1998). Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States Metropolitan areas. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18:S30-S36.
36. Gold, M., Gafni, A., Nelligan, P., Millson, P. (1997). Needle exchange programs: an economic evaluation of a local experience. Canadian Medical Association Journal 157:255-262.
37. Gray, J. (1995). Operating needle exchange programmes in the hills of Thailand. AIDS Care 7:489-499.
38. Guydish, J., Bucardo, J., Clark, G., Bernheim, S. (1998). Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Substance Use & Misuse 33:1173-1196.
39. Guydish, J., Bucardo, J., Young, M., Woods, W., Grinstead, O. (1993). Eualuating needle exchange: are there negative effects? AIDS 7:871-876.
40. Guydish, J., Clark, G., Garcia, D., Bucardo, J. (1995). Evaluation of needle exchange using street-based survey methods. Journal of Drug Issues 25:33-41.
41. Hagan, H., Des Jarlais, D. C., Friedman, S. R., Purchase, D., Alter, M. J. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health 85:531-537.
42. Hagan, H., McGough, J. P., Thiede, H., Hopkins, S., Duchin, J., Alexander, E. R. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 19:247-252.
43. Hartgers, C., Buning, E. C., van Santen, G. W., Verster, A. D., Coutinho, R. A. (1989). The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS 3:571-576.
44. Hartgers, C., van Ameijden, E. J., van den Hoek, J. A., Coutinho, R. A. (1992). Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting users. Public Health Reports 107:675-681.
45. Health Outcomes International (HOI), NDARC, Drummond M. (2002). Return on Investment in Needle and Syringe Programs in Australia. Canberra: Commonwealth Department of Health and Ageing.
46. Heimer, R. (1998). Can syringe exchange serve as a conduit to substance abuse treatment? Journal of Substance Abuse Treatment 15:183-191.
47. Heimer, R., Kaplan, E. H., Khoshnood, K., Jariwala, B., Cadman, E. C. (1993). Needle exchange decreases the prevalence of HIV-1 Proviral DNA in returned syringes in New Haven, Connecticut. The American Journal of Medicine 95:214-220.
48. Heimer, R., Khoshnood, K., Bigg, D., Guydish, J., Junge, B. (1998). Syringe use and reuse: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18:S37-S44.
49. Holtgrave, D. R., Pinkerton, S. D., Jones, T. S., Lurie, P., Vlahov, D. (1998). Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18:S133-S138.
50. Hurley, S. F., Jolley, D. J., Kaldor, J. M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet 349:1797-1800.
51. Inciardi, J. A., Page, J. B., McBride, D. C., Chitwood, D. D., McCoy, C. B., McCoy, H. V., Trapedo, E. J. (1994). The risk of exposure to HIV-contaminated needles in shooting galleries. In: Inciardi, J. A., McElrath, K., eds. The American Drug Scene. Los Angeles: Roxbury Press.
52. Institute of Medicine of the National Academy of Science. (2001). No Time to Lose: Getting More from HIV Prevention. Washington, DC: National Academies Press.
53. International Narcotics Control Board. (2004). Report of the International Narcotics Control Board for 2003. Vienna: International Narcotics Control Board.
54. Jacobs, P., Calder, P., Taylor, M., Houston, S., Saunders, L. D., Albert, T. (1999). Cost effectiveness of Streetworks' needle exchange program of Edmonton. Canadian Medical Association Journal 90:168-171.
55. Jenkins, C., Rahman, H., Saidel, T., Jana, S., Hussain, A. M. Z. (2001). Measuring the impact of needle exchange programs among injecting drug users through the National Behavioural Surveillance in Bangladesh. AIDS Education & Prevention 13:452-461.
56. Junge, B., Valente, T., Latkin, C., Riley, E., Vlahov, D. (2000). Syringe exchange not associated with social network formation: results from Baltimore. AIDS 14:423-426.
57. Kahn, J., Haynes Sanstad, K. C. (1997). The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS & Public Policy Journal 12:21-30.
58. Kahn, J. G. (1998). Economic evaluation of primary HIV prevention in injection drug users. Handbook of Economic Evaluation HIV Prevention Programs. New York: Plenum Press.
59. Kahn, J. G., Washington, A. E., Showstack, J. A. (1992). Updated Estimates of the Impact and Cost of HIV Prevention in Injection Drug Users. Prepared for the Centers for Disease Control. San Francisco: Institute for Health Policy Studies, School of Medicine, University of California, San Francisco.
60. Kahn, J. G., DeCarlo, P. (1995). Is HIV Prevention a Good Investment? Infact sheet San Francisco CA: Center for AIDS Prevention Studies (CAPS), University of California, San Francisco.
61. Kaplan, E. H., Heimer, R. (1995). HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. Journal of Acquired Immune Deficiency Syndromes 10:175-176.
62. Kaplan, E. H., Khoshnood, K., Heimer, R. (1994). A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange? American Journal of Public Health 84:1991-1994.
63. Kaplan, E. H. (1991). Evaluating needle exchange programs via syringe tracking and testing. AIDS and Public Policy 6:109-115.
64. Keene, J., Stimson, G. V., Jones, S., Parry-Langdon, N. (1993). Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. Addiction 88:1063-1070.
65. Klee, H., Faugier, J., Hayes, C., Morris, J. (1991). The sharing of injection equipment among drug users attending prescribing clinics and those using needle exchange. British Journal of Addiction 86:217-223.
66. Klee, H., Morris, J. (1995). The role of needle exchanges in modifying sharing behaviour: cross-study comparisons 1989-1993. Addiction 90:1635-1645.
67. Kumaranayake, L., Vickerman, P., Walker, D., Samoshkin, S., Romantzov, V., Emelyanova, Z., Zviagin, V., Watts, C. (2004). The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction 99:1565-1576.
68. Kumaranayake, L. V., Walker, P., Samoshkin, D., Romantzov, V., Emelyanova, Z., Zviagin, V., Watts, C. (2004). The Cost-Effectiveness of HIV Preventive Measures Among Injecting Drug Users in Svetlogorsk, Belarus: Addiction 99:1565-1571.
69. Latkin, C. A., Forman, V. L. (2001). Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 27:398-404.
70. Laufer, F. N. (2001). Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes 28:273-278.
71. Lima, E. S., Friedman, S. R., Bastos, F. I., Telles, P. R., Friedmann, P., Ward, T. P., des Jarlais, D. C. (1994). Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment in Rio de Janeiro. Addiction 89:689-698.
72. Ljungberg, B., Christensson, B., Tunving, K., Andersson, B., Landvall, B., Lundberg, M., Zall-Friberg, A. C. (1991). HIV prevention among injecting drug users: three years of experience from a syringe exchange program in Sweden. Journal of Acquired Immune Deficiency Syndromes 4:890-895.
73. Lowndes, C. M., Alary, M. (1998). Re: High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study [letter]. American Journal of Epidemiology 148:713-714.
74. Lurie, P., Drucker, E. (1997). An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. The Lancet 349:604-608.
75. Lurie, P., Drucker, E. (1997). An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. The Lancet 349:604-608.
76. Lurie, P., Gorsky, R., Jones, S. T., Shomphe, L. (1998). An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18:S126-S132.
77. Lurie, P., Reingold, A. L., eds. (1993). The Public Health Impact of Needle Exchange Programs in the United States and Abroad., Vol. 1. Atlanta, GA: Centers for Disease Control and Prevention.
78. MacCoun, R. J., Reuter, P. (2001). Drug War Heresies: Learning from Other Vices, Times, and Places. London: Cambridge University Press.
79. McAllister, W. B. (2000). Drug Diplomacy in the Twentieth Century: An International History. London: Routledge.
80. McCoy, C. B., Shapshak, P., Metsch, L. R., Rivers, J. E., McCoy, H. V., Weatherby, N. L., Shah, S. M., Chitwood, D. D. (1995b). HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. Arch Immunol Ther Exp 43:1-9.
81. McCoy, C. B., Shapshak, P., Shah, S. M., McCoy, H. V., Rivers, J. E., Page, J. B., Chitwood, D. D., Weatherby, N., Inciardi, J. A., McBride, D. C., Mash, D. C., Watters, J. K. (1995a). HIV-1 prevention: interdisciplinary studies and reviews on efficacy of bleach and compliance to bleach prevention protocols. Paper presented at Workshop on Needle Exchange and Bleach Distribution Programs, Washington, DC.
82. McCoy, A. W. (2003). The Politics of Heroin: CIA Complicity in the Global Drug Trade. Chicago, IL: Lawrence Hill Books.
83. Monterroso, E. R., Hamburger, M. E., Vlahov, D., Des Jarlais, D. C., Ouellet, L. J., Altice, F. L., Byers, R. H., Kerndt, P. R., Watters, J. K., Bowser, B. P., Fernando, M. D., Holmberg, S. D. (2000). Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 25:63-70.
84. National Commission on AIDS. (1991). The Twin Epidemics of Substance Use and HIV. Washington, DC.
85. National Institutes of Health Consensus Panel. (1997). Interventions to Prevent HIV Risk Behaviors. Bethesda, MD: NIH.
86. Nelles, J., Harding, T. (1995). Preventing HIV transmission in prison: a tale of medical disobedience and Swiss pragmatism. The Lancet 346:1507-1508.
87. Nelson, K. E., Celentano, D. D., Eiumtrakol, S., Hoover, D. R., Beyrer, C., Suprasert, S., Kuntolbutra, S., Khamboonruang, C. (1996). Changes in sexual behaviour and a decline in HIV infection among young men in Thailand. The New England Journal of Medicine 335:297-303.
88. Nelson, K. E., Vlahov, D., Cohn, S., Lindsay, A., Solomon, L., Anthony, J. C. (1991). Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA 266:2259-2261.
89. Normand, J., Valhov, D., Moses, L. E., eds. (1995). Preventing HIV Transmission The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press.
90. Oliver, K. J., Friedman, S. R., Maynard, H., Magnuson, L., Des Jarlais, D. C. (1992). Impact of a needle exchange program on potentially infectious syringes in public places. Journal of Acquired Immune Deficiency Syndromes 5:534-535.
91. Oliver, K. J., Maynard, H., Friedman, S. R., Des Jarlais, D. C. (1994). Behavioral and community impact of the Portland syringe exchange program. In: Normand, J., Vlahov, D., Moses, L. E., eds. Proceedings: Workshop on Needle Exchange and Bleach Distribution Programs. Washington, DC: National Academy Press, pp. 35-46.
92. Page, J. B., Chitwood, D. D., Smith, P. C., Kane, N., McBride, D. C. (1990). Intravenous drug use and HIV infection in Miami. Medical Anthropology 4:56-71.
93. Paone, D., Cooper, H., Alperen, J., Shi, Q., Des Jarlais, D. C. (1999). HIV risk behaviors of current sex workers attending syringe exchange: The experiences of women in five US cities. AIDS Care 11:269-280.
94. Paone, D., Des Jarlais, D. C., Caloir, S., Friedman, P. B., Ness, I., Friedman, S. R. (1994). New York City syringe exchange: an overview. Paper presented at Workshop on Needle Exchange and Bleach Distribution Programs, September 27-28, 1993. Washington, D.C.: National Academy Press.
95. Paone, D., Des Jarlais, D. C., Shi, Q. (1998). Syringe exchange use and HIV risk reduction over time. AIDS 12:121-123.
96. Patrick, D. M., Strathdee, S. A., Archibald, C. P., Ofner, M., Craib, K. J., Cornelisse, P. G. (1997). Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS 8:437-445.
97. Peak, A., Rana, S., Maharjan, S. H., Jolley, D., Crofts, N. (1995). Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme. AIDS 9:1067-1070.
98. Power, R., Nozhkina, N. (2002). The value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS 16:303-304.
99. Quan, V. M., Chung, A., Abdul-Quader, A. S. (1998). The feasibility of a syringe-needle-exchange program in Vietnam. Substance Use & Misuse 33:1055-1067.
100. Safaeian, M., Brookmayer, R., Vlahov, D., Latkin, C., Harx, M., Strathdee, S. A. (2002). Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. American Journal of Epidemiology 155:169-175.
101. Samuels, J. S., Vlahov, D., Anthony, J. C., Solomon, L., Celentano, D. D. (1991). The practice of "frontloading" among intravenous drug users: association with antibody. AIDS 5:343-345.
102. Satcher, D. (2000). Evidence-Based Findings on the Efficacy of Syringe Exchange Programs: An Analysis of the Scientific Research Completed Since April 1998. Washington, DC: Department of Health and Human Services.
103. Schechter, M. T. S., Cornelisse, Peter, G. A., Currie, S., Patrick, D. M., Rekart, M. L., O'Shaughnessy, Michael, V. (1999). Do needle exchange programs increase the spread of HIV among injection drug users: an investigation of the Vancouver outbreak. AIDS 13:F45-F51.
104. Schoenbaum, E. E., Hartel, D. M., Gourevitch, M. N. (1996). Needle exchange use among a cohort of injecting drug users. AIDS 10:1729-1734.
105. Sears, C., Guydish, J. R., Weltzien, E. K., Lum, P. J. (2001). Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 27:193-201.
106. Shah, S. M., Shapshak, P., Rivers, J. E., Stewart, R. V., Weatherby, N. L., Xin, K. Q., Page, J. B., Chitwood, D. D., Mash, D. V., Vlahov, D., McCoy, C. B. (1996). Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 11:301-306.
107. Shapshak, P., Fujimura, R. K., Page, J. B., Segal, D., Rivers, J. E., Yang, J., Shah, S. M., Graham, G., Metsch, L., Weatherby, N., Chitwood, D. D., McCoy, C. B. (2000). HIV-1. RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. Drug & Alcohol Dependence 58:153-157.
108. Singer, M., Himmelgreen, D., Weeks, M. R., Radda, K. E., Martinez, R. (1997). Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Medical Anthropology 18:107-130.
109. Strathdee, S. A., Celentano, D. D., Shah, N., Lyles, C., Stambolis, V. A., Macal, G., Nelson, K., Vlahov, D. (1999). Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health 76:448-460.
110. Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G., Rekart, M. L., Montaner, J. S., Schechter, M. T., O'Shaughnessy, M. V. (1997). Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11:F59-F65.
111. Strathdee, S. A., Vlahov, D. (2001). The effectiveness of needle exchange programs: a review of the science and policy. AIDScience 1:1-33.
112. Telles, P. R., Bastos, F. I., Guydish, J., Inciardi, J. A., Surratt, H. L., Pearl, M., Hearst, N. (1997). Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS 11(Suppl 1):S35-S42.
113. UNAIDS. (2002). Report on the Global HIV/AIDS Epidemic 2002. Geneva: United Nations.
114. UNAIDS. (2004). United States of America: Country HIV and AIDS Estimates, end 2003. (Accessed on 27 June 2005) http://www.unaids.org/EN/ geographical+area/by+country/united+states+of+america.asp
115. UNDCP. (2002). Flexibility of Treaty Provisions as Regards Harm Reduction Approaches Legal Affairs Section. Vienna: United Nations International Drug Control Programme (UNDCP).
116. Ungchusak, K., Sriprapandh, S., Pinichpongse, S., Kunasol, P., Thanprasertsuk, S. (1989). First national sentinel seroprevalence survey of HIV-1 infection in Thailand, June 1989. Thai AIDS Journal 1:57-74.
117. van Ameijden, E. J., Coutinho, R. A. (2001). Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology & Community Health 55:356-363.
118. van Ameijden, E. J., Coutinho, R. A. (1998). Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS 12:625-633.
119. van Ameijden, E. J., Langendam, M. W., Notenboom, J., Coutinho, R. A. (1999). Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. Addiction 94:1051-1061.
120. van Ameijden, E. J., van den Hoek, A. R., Coutinho, R. A. (1994). Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. American Journal of Public Health 84:275-281.
121. van Ameijden, E. J., van den Hoek, J. A. R., van Haastrecht, H. J. A., Coutinho, R. A. (1992). The harm reduction approach and risk factors for human immunodeficiency virus seroconversion in injecting drug users, Amsterdam. Am. J. Epidemiol 136:236-243.
122. van Haastrecht, H. J., van Ameijden, E. J., van den Hoek, J. A., Mientjes, G. H., Bax, J. S., Coutinho, R. A. (1996). Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol 143:380-391.
123. Vickerman, P., Watts, C. (2002). The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: model predictions. International Journal of Drug Policy 13:149-164.
124. Vlahov, D., Junge, B., Brookmeyer, R., Cohn, S., Riky, E., Armenian, H., Beilenson, P. (1997). Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes 16:400-406.
125. Vogt, R. L., Breda, M. C., Des Jarlais, D. C., Gates, S., Whiticar, P. (1998). Hawaii's statewide syringe exchange program. American Journal of Public Health 88:1403-1404.
126. Watters, J. K., Estilo, M. J., Clark, G. L., Lorvick, J. (1994). Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 271:115-120.
127. Weaver, H., Smith, G., Kippax, S. (2005). School-based sex education policies and indicators of sexual health among young people: a comparison of the Netherlands, France, Australia and the United States. Computer Science Education 5:171-188.
128. Weber, U., Schneider, W. (1998). Syringe exchange in Germany. Substance Use & Misuse 33:1093-1112.
129. Wodak, A., Cooney, A. (2004). Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS among Injecting Drug Users. Geneva: World Health Organization.
130. Wodak, A., Dolan, K., Imrie, A. A., Gold, J., Wolk, J., Whyte, B. M., Cooper, D. A. (1987). Antibodies to the HIV virus in needles and syringes used by intravenous drug abusers. Medical Journal of Australia 147:275-276.
131. Wolk, J., Wodak, A., Guinan, J. J., Macaskill, P., Simpson, J. M. (1990). The effect of a needle and syringe exchange on a methadone maintenance unit. British Journal of Addiction 85:1445-1450.